Buclizine

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

R06AE01

CAS registry number (Chemical Abstracts Service)

0000082-95-1

Chemical Formula

C28-H33-Cl-N2

Molecular Weight

433

Therapeutic Categories

Antiallergic agent

Histamine, H₁-receptor antagonist

Chemical Name

Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-[[4-(1,1-dimethylethyl)phenyl]methyl]-

Foreign Names

• Buclizinum (Latin)
• Buclizin (German)
• Buclizine (French)
• Buclizina (Spanish)

Generic Names

• Buclizina (OS: DCIT)
• Buclizine (OS: DCF, BAN)
• AR 2526 (IS)
• Histabutizine (IS)
• Buclizine Hydrochloride (OS: BANM, USAN)
• UCB 4445 (IS)
• Buclizine Hydrochloride (PH: BP 2010)

Brand Names

• Buclina
  Vedim, Portugal; Sanofi-Aventis, Brazil



• Buclizine Beacons
  Beacons, Singapore



• Longifene
  Pierre Fabre, Belgium; UCB, India; UCB, Luxembourg; UCB, Malaysia; UCB, Oman; UCB, Turkey; UCB, Taiwan; UCB, South Africa



• Postafen
  Sanofi-Aventis, Brazil



• Trianorexil
  Patric, Colombia



• Vomifene (Buclizine and Pyridoxine)
  Adcock Ingram Pharmaceuticals, South Africa

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
DCIT	Denominazione Comune Italiana
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.